Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.
12 小时
GlobalData on MSNKeymed’s Stapokibart approved by NMPA for seasonal allergic rhinitisFailed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...
We find diamonds in the rough and we cut and finish them,' Roquefort boss Ajan Reginald says, summing up the company's ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果